# H.J. Jiang

> H.J. Jiang is a Series B investor at TF Capital backing Health Care and Therapeutics. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [TF Capital](https://shizune.co/investors/profile/tf-capital)
- Total investments: 1
- Last investment: Aug 2020
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/kevin-chiang-21699698/

H.J. Jiang is a Series B investor at TF Capital focused on Health Care and Therapeutics. H.J. Jiang is founder of TF Capital.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Exegenesis Bio | Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development. |  | Series B | Aug 03, 2020 |  |

1 of 1 investments shown.

## Co-investors
- [Boyuan Capital](https://shizune.co/investors/profile/boyuan-capital-4fca) — VC Fund, 1 deal together
- [K2VC](https://shizune.co/investors/profile/k2-vc) — VC Fund, 1 deal together
- [Kaitai Capital](https://shizune.co/investors/profile/kaitai-capital) — VC Fund, 1 deal together
- [Legend Capital](https://shizune.co/investors/profile/legend-capital) — VC Fund, 1 deal together

## About TF Capital

VC Fund · Pudong, China

TF Capital is a proprietary trading company that specializes in foreign exchange and invests in early stage ventures.

4 contacts available at TF Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Dr. Zhang Yibo | Partner | https://shizune.co/investors/profile/dr-zhang-yibo |
| H.J. Jiang | Founder & CEO | https://shizune.co/investors/profile/kevin-chiang-fda9 |
| Wei Cheng | Managing Director | https://shizune.co/investors/profile/wei-cheng-2639 |
| Yi Liu | Director | https://shizune.co/investors/profile/yi-liu-0a01 |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does H.J. Jiang invest in?

H.J. Jiang invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did H.J. Jiang last invest?

The most recent investment recorded for H.J. Jiang closed in Aug 2020. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co